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Incubation of peritoneal macrophages with /3-phorbol 12,13-dibutyrate promotes a time-dependent release of NO to the incubation medium. This 
effect was antagonized by LPS, a well known inducer of nitric oxide synthase (NOS) expression in macrophages, and was inhibited by .V”-methyl- 
t_-arginine and N”-nitro-L-arginine. An increase in intracellular cGMP and NOS activity was observed in parallel with NO release. The induction 
of NOS was accompanied by a stimulation of arginine influx within the cell. These results suggest hat activation of protein kinase C by phorbol 
esters is sufficient to promote NOS induction in macrophages. 
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1. INTRODUCTION 
Nitric oxide has emerged as an important intra- and 
intercellular regulatory molecule with functions as di- 
verse as vasodilatation, neural communication or host 
defense [l-3]. Nitric oxide synthase is the enzyme in- 
volved in the production of nitric oxide from molecular 
0, and arginine, and appears to be a growing family of 
isoenzymes [1,2]. At least three different isoforms have 
been identified in mammalian tissues: neural and endo- 
thelial cells contain two different, although related, con- 
stitutive isoenzymes that require Ca’+ and calmodulin 
to be active, whereas the isoenzyme xpressed in macro- 
phages after stimulation with cytokines and endotoxins 
does not require these cofactors [2,3]. 
The expression of the Ca*‘-independent cytokine-in- 
ducible NOS has been described in various cell types, 
in addition to macrophages [4-61. In hepatocytes, a 
form of NOS induced by phorbol esters has been re- 
ported [7], although the correspondence of this NOS 
with the macrophage isoenzyme remains to be estab- 
lished in view of the calmodulin requirement described 
for the hepatic NOS induced in response to LPS [S]. 
Macrophage NOS is by far the best characterized isoen- 
zyme among the cytokine-inducible forms, both from a 
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biological and chemical point of view, and the presence 
of a complex regulatory mechanism in the control of 
NOS expression by cytokines and endotoxins has been 
shown [9,10]. Therefore we decided to investigate 
whether activation of macrophage PKC with phorbol 
esters or with Ca*’ and 1 ,Zdiacylglycerol promotes the 
expression of NOS. 
In this work we show that PKC activation by phorbol 
esters is sufficient to promote the expression of induci- 
ble NOS in macrophages and elicits an increase in the 
arginine influx to the cell. A clear antagonism exists 
between phorbol esters and LPS in promoting NOS 
expression. 
2. MATERIALS AND METHODS 
2.1. Chemicals 
[U-Ylarginine and a cGMP assay kit were from Amersham. 2’,5’- 
ADP-Sepharose was from Pharmacia. LPS was from Difco. and 
Dowex AG50W-X8 was from Bio-Rad. Nitrate reductase from Asper- 
gillus and other enzymes were from Boehrmger Mannheim. (6R)- 
5,6,7&tetrahydrobiopterin (BH,) was from Dr. B. Schircks Laborato- 
ries (Jona, Switzerland). Arginine derivatives and other chemicals and 
biochemicals were from Sigma or Merck. 
2.2. Cell cultures 
Peritoneal macrophages were prepared following previous proto- 
cols [ll]. Briefly, anesthetized 2-month-old male rats were injected 
intraperitoneally with 50 ml of sterile PBS and after 10 min the ascitic 
liquid was removed. Rats suffering hemorrhaging were discarded. The 
ascitic fluid was centrifuged (10 min; 200 x g) and the cell pellet 
washed twice with PBS. Cells were seeded at 106/cm2 in RPM1 1640 
supplemented with 10% of heat-inactivated FCS, and adherent cells 
were maintained overnight in this medium. Experiments were carried 
out in Phenol red-free DMEM medium supplemented with 1 mM 
arginine and 10% heat-inactivated FCS. 
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2.3. NO assay 
Release of NO by the cell culture was determined by the accumula- 
tion of nitrite and nitrate (total NO) as follows: 200 ~1 of culture 
medium were incubated with 0.5 U of nitrate reductase (Boehringer) 
m the presence of 50 PM NADPH and 5 ,KM FAD [12]. Excess 
NADPH, which interferes with the chemical determination of nitrite. 
was oxidized with 0.2 mM pyruvate and 1 yg of lactate dehydrogenase. 
Nitrite was determined with Greiss reagent [13] by adding 1 mM 
sulfanilic acid and 100 mM HCl (final concentration). After incuba- 
tion for 5 min the tubes were centrifuged in an Eppendorf centrifuge 
and 150 ~1 of supernatant were transferred to a 96-well microplate. 
After a first reading of the absorbance at 548 nm, 50 ~1 of naphthyle- 
nediamme (1 mM in the assay) were added. The reaction was com- 
pleted after 15 min of incubation and the absorbance at 548 nm was 
compared with a standard of NaNO,. The absorbance corresponding 
at 0 time was subtracted. Solutions of NO were prepared by bubbling 
the gas through a helium-treated phosphate-buffered saline (PBS) 
solution. The NO concentration in the medium was determined with 
Greiss reagent. 
2.4. NOS activity determination 
NOS activity was followed by the release of [U-‘4C]citrulline from 
[U-‘4C]arginine in the presence of 1 PM BH, and 0.5 mM NADPH. 
Cell pellets were homogenized as previously described and the enzyme 
activity was measured after partial purification by a 2’,5’-ADP-Sepha- 
rose chromatography column as described [7,14]. One unit of NOS 
was defined as producing 1 nmol of NO per minute. 
2.5. cGMP determmation 
To measure the intracellular concentration of cGMP the cell layer 
was washed with 1 ml of ice-cold PBS, followed by the addition of 0.5 
ml of a mixture of ethanol/water (2:l). After freezing and thawing to 
favor cell disruption, the cells were homogenized, centrifuged in an 
Eppendorf centrifuge for 10 min and the resulting supernatants were 
speed-vacuum dried and resuspended in the buffer recommended by 
the supplier of the cGMP assay kit (Amersham). The protein concen- 
tration was measured in the pellet after ethanolic precipitation. 
2.6. Measurement of arginine in&u 
Arginine influx in macrophages was measured after washing the cell 
layer twice with PBS at 37°C followed by incubation of the macroph- 
ages with [LJ-‘4C]arginine (100 mCi/mol) for 30 and 60 s. The dishes 
were rapidly washed twice with 1 ml of ice-cold PBS and the radioac- 
tivity mcorporated was measured. Linearity was observed at least 
during the first 30 s of incubation. 
2.7. Protem assay 
Protein was assayed according to Bradford [15] using bovine serum 
albumin as a standard. 
3. RESULTS 
3.1. PDBu induces NO release in cultured peritoneal 
macrophages 
Primary cultures of adherent macrophages were chal- 
lenged with 100 nM PDBu and NO release was meas- 
ured at various times by the method of Greiss (nitrite 
plus nitrate). As Fig. 1A shows, the half-maximal effect 
was observed after 4 h of exposure of the culture to 
PDBu. The production of NO by cells incubated with 
LPS was lower than after exposure to phorbol esters 
(53% after 4 h of incubation). Fig. 1B shows the dose 
dependence for NO release after stimulation with 
PDBu, and the absence of effect when macrophages 
were incubated with the biologically inactive phorbol 
ester isomer 4-a-PDD. The release of NO elicited by 
PDBu fits with the range of concentration required to 
activate PKC by phorbol esters, and taken together 
these results suggest that PKC activation is involved 
and may be sufficient to induce NO release by cultured 
macrophages. 
Macrophages release NO after stimulation with cy- 
tokines such as LPS or INF-y, and a synergism has been 
described for the effect of these cytokines on NOS in- 
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Fig. 1. NO release by cultured peritoneal macrophages incubated with phorbol esters and LPS. Macrophages (7 x 105) were incubated for 18 h 
in RPM1 1640 medium containing 10% heat-inactivated FCS and after extensive washing with PBS, the medium was replaced by phenol red-free 
DMEM medium containing 1 mM argmine and NO was measured using the Greiss reagent. Cells were challenged without (0) or with 100 nM 
PDBu (o), 50 ,&ml LPS (A) or 100 nM PDBu plus 50 &ml of LPS (0) (panel A). The dose-dependent effect of PDBu (0) and a-PDD (0) were 
assayed after 4 h of incubation (panel B). Results show a representative experiment (panel A) or the means f S.E.M. of 4 independent cell 
preparations, assayed per duplicate (panel B). 
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Table I 
NOS induction by phorbol esters 
Cultured macrophages (10’ cells) were incubated with the indicated 
substances for 4 h. At the end of the incubation period the cell layers 
were homogenized and NOS was partially purified by 2’S’-ADP- 
Sepharose chromatography. The enzyme activity was followed by the 
release of [U-“‘C]citrulline. The intracellular concentration of cGMP 
was measured using a commercial assay kit. Results are the mean of 
two (NOS) or the mean f S.E.M. of three (cGMP) experiments. 
Ligand 
None 
PDBu. 100 nM 
LPS, 50 pg/ml 
PDBu + LPS 
PDBu + L-NNA, 
NOS 
(units/mg protein) 
6.3 
43.9 
14.7 
ND 
cGMP 
(pmol/mg protein) 
1.3 + 0.2 
5.9 + 0.4 
2.4 f 0.2 
2.1 * 0.3 
100 PM 
NO, 3 PM 
ND, not determined. 
0.8 1.3 f 0.2 
ND 9.3 * 1.2 
duction and NO release [9,10]. In contrast, a clear an- 
tagonism between PDBu and LPS in NO release was 
evidenced in macrophages (Fig. 1A). This response was 
absent in cells incubated with LPS and a-PDD (not 
shown). 
3.2. PKC activation is involved in NOS induction 
The release of NO by macrophages elicited by PDBu 
correlates well with the expression of NOS activity 
(Table I) as suggested both by the time-course profile 
of NO accumulation (Fig. lA), and by the fact that NO 
release was inhibited in cells treated with cycloheximide 
(Table II), indicating that the integrity of the protein 
synthesis machinery was necessary for the effect to be 
observed. Moreover, the presence in the incubation me- 
dium of the NOS inhibitor L-NMA, but not the inactive 
isomer D-NMA, efficiently blocked the NO release by 
the cells (Table II). 
To further analyze the mechanism by which PDBu 
promotes NO release in cultured macrophages, the ef- 
fect of some putative PKC activity modulators was as- 
sayed. As Table II shows, the incubation of the macro- 
phages with the PKC inhibitors calphostine C (81% 
inhibition) and the isoquinoline H-7 (60% inhibition) 
abolishes the effect of PDBu on NO release. However, 
such is not the case for staurosporine, also a well known 
inhibitor of PKC, that only inhibits 45% of the PDBu 
effect. The biochemical basis for these different re- 
sponses to the PKC inhibitors are unknown but may be 
related both to the fate of PKC after prolonged incuba- 
tion of the macrophages with phorbol esters (proteoly- 
sis), and to a differential substrate-specificity for the 
PKC inhibitors used, in the sense described in an earlier 
work [16]. 
The observation that /I-TGF, insulin and INF-)I 
block the stimulatory effect of PBDu is also interesting. 
Conversely, incubation with EGF even potentiates the 
action of PDBu (Table II), suggesting that a complex 
modulation of NOS expression exists between the cy- 
tokines. 
3.3. PKC activators increase cGMP in macrophages 
One of the intracellular targets of NO is the activation 
of soluble guanylate cyclase [17], and accordingly, the 
intracellular concentration of cGMP will increase in 
macrophages timulated with phorbol esters or cytoki- 
nes. As Table I shows, cGMP increased in cells stimu- 
lated with either PDBu (45fold increase) or LPS (1.8- 
fold increase), in agreement with their effects on the NO 
concentration. However, when both PDBu and LPS are 
simultaneously added only a 1.6-fold increase in cGMP 
is observed. Moreover, in the presence of the NOS in- 
hibitor L-NNA, PDBu fails to produce changes in 
cGMP, which suggests that NO release is required to 
promote guanylate cyclase activation. The changes in 
cGMP produced by PDBu are in the range of those 
reached in cells incubated with a solution of NO (3 PM). 
3.4. Arginine transport is stimulated by phorbol esters 
and cytokines 
Since macrophage NOS appears not to be regulated 
by enzyme effecters as occurs for the Ca”/calmodulin- 
dependent constitutive isoenzyme of neural and endo- 
thelial tissues, the arginine influx to the cell was studied 
as a possible relevant factor in the control of enzyme 
activity. As shown in Fig. 2A, at arginine concentra- 
tions in the low micromolar range, similar to those pre- 
vailing in plasma, treatment of the cells with LPS or 
PDBu increases arginine transport by 5.0- and 5.7-fold, 
Table II 
Modulation of NO release in cultured peritoneal macrophages 
Macrophages (7 x 10’) were incubated for 4 h with the indicated cy- 
tokines and substances and NO production was measured using the 
Greiss reagent. Results are the means f S.E.M. of three independent 
cell preparations. 
Ligand(s) NO release (nmollmg protein) 
None PDBu LPS (50 j&ml) 
(100 nM) 
None 1.6 f 0.2 12.2 f 1.7 6.5 ? 0.8 
Cycloheximide, 1 ,uM 1.7 + 0.2 1.6 ?r 0.1 1.5 f 0.1 
Staurosporine, 500 nM 1.6 f 0.1 7.4 f 0.4 4.9 f 0.6 
Calphostine C, 500 nM 1.9 f 0.3 3.9 + 0.5 ND 
H-7, 10 /fM ND 5.8 +_ 0.3 ND 
I ,2-DOG, 2 &ml 6.3 f 0.5 17.0 f 0.3 2.7 f 0.1 
L-NMA, 100 PM 1.6 f 0.3 1.5 f 0.5 1.4 f 0.3 
D-NMA, 250 ,uM 1.7 + 0.2 9.9 + 0.6 5.9 + 0.4 
/%TGF, 0.1 ng/ml 3.3 f 0.2 1.7 f 0.1 ND 
EGF, 100 @ml 10.0 f 0.5 19.8 ? 1.1 6.0 f 1.0 
Insulin, 20 nM 2.0 f 0.1 4.6 + 0.4 ND 
IFN-y 2.4 + 0.3 3.8 + 0.5 4.3 f 0.2 
ND, not determined. 
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Fig. 2. Effect of PDBu on arginine influx. Macrophages (2 x 106) were incubated with 100 nM PDBu or SO&ml of LPS for 4 h and the transport 
of [U-%]arginine (5 PM) was measured (panel A). The rate of arginine influx was calculated by the measurement of the radioactivity incorporated 
at 30 and 60 s. The dose-dependent influx was assayed in unstimulated (0) or 4-h treated cells with 100 nM PDBu (0) (panel B). The inset shows 
the Lineweaver-Burk plot for the arginine uptake corresponding to the data given in panel B. Results are means f S.E.M. of 3 independent 
determinations. 
respectively. The Lineweaver-Burk plot for arginine in- 
flux (inset) shows a complex behavior that may be inter- 
preted either by the presence of two transport systems 
or as a process with negative cooperativity [18]. The 
observation that both LPS and PDBu stimulate argin- 
ine influx suggests the existence of common pathways 
in NOS expression and regulation (via substrate availa- 
bility) by both factors. 
4. DISCUSSION 
Expression of the calcium-independent NOS in mac- 
rophages by cytokines such as INF-y, a-TNF, LPS or 
by bacterial endotoxins is probably the best character- 
ized system for the study of the expression of the induc- 
ible isoenzyme [2,3,9,10]. However, the intracellular sig- 
nals involved in the control of the expression of this 
NOS isoenzyme are unknown. Our results provide an 
additional mechanism to induce NOS in macrophages 
after activation of PKC by phorbol esters, and extend 
our initial observation in cultured hepatocytes [7], sup- 
porting the view that NOS induction by phorbol esters 
might be a middle-term (hours) response to PKC activa- 
tion in different cell systems. This involvement of PKC 
as the initial event in the expression of NOS in macroph- 
ages, and in the absence of other cooperative signals (i.e. 
calcium mobilization), is supported by the fact that this 
kinase is the biological receptor of phorbol esters in 
non-neural tissues, in which the amount of n-chimaer- 
ine, the other known phorbol ester receptor, is negligi- 
ble [19]. Besides, the possibility of the involvement of 
138 
PKC in the mechanism of NOS induction triggered by 
some cytokines cannot be excluded as suggested by the 
effect of INF-y [20]. 
The molecular basis for the antagonism between 
phorbol esters and LPS in promoting NOS induction 
deserves further study. In LPS-activated macrophages, 
it has been shown that PKC stimulation is an early 
target as result of the release of metabolites (i.e. ara- 
chidonic acid) following exposure of the cells either to 
LPS or its derivatives, the biologically active moieties 
lipid A and lipid X [21,22]. Indeed, both lipids A and 
X activate PKC in vitro [22,23]. However, it is possible 
that the PKC subspecies activated by LPS through its 
intracellular active metabolites, might be different from 
those elicited by phorbol esters, which, besides promot- 
ing PKC activation also trigger the proteolytic degrada- 
tion of the kinase, and one of its fragments exhibits an 
unregulated protein kinase catalytic activity (also 
termed PKM), which in turn may initiate an additional 
phosphorylation cascade [16,24]. Alternatively, phorbol 
esters may alter the transmembrane signaling pathway 
of LPS, causing a blockage of the biological response 
to this molecule, for example the inhibition by phorbol 
esters of the differentiation and clonal expansion of 
LPS-activated B-cells [25]. 
The antagonism between PDBu and LPS on NOS 
induction may also be interpreted in the light of the 
cross-regulatory effects observed among different cy- 
tokines. Incubation of LPS-activated peritoneal neutro- 
phils with IL-8 blocks both the release of NO and NOS 
induction at the transcriptional level [26], and the same 
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antagonistic response is observed between /3-TGF and 
IFN-)I in the NO release in macrophages 1271. There- 
fore, because the enzymatic activity of NOS is not regu- 
lated at the post-transcriptional level, it seems that a 
complex regulation of the control of NOS expression by 
cytokines operates. 
Finally, the assessment of sustained PKC activation 
as a self-sufficient signal to elicit NO release from mac- 
rophages, and the characterization of some of the tran- 
scriptional factors stimulated after PKC activation (AP- 
1 transcriptional complex), may help to unravel the 
mechanism involved in the expression of inducible 
NOS. 
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